Sign in

Elise Lepeltier

@elepeltier.bsky.social
95 followers 140 following 82 posts
PostsRepliesMedia
Reposted by Elise Lepeltier
SFNano_official @sfnano.bsky.social · 02/07/2025
Registration is open for the 11th SFNano Annual Meeting 2025 that will take place on November 24th – 26th in Lyon, France! Early bird registration fee until October 15th. Abstract submission deadline is on September 15th. For more information and registration: sfnano2025.univ-lyon1.fr/fr
052
Reposted by Elise Lepeltier
LabMINT @labmint.bsky.social · 12/06/2025
Today it is the MINT Day! A good occasion to share science and good moments together. We are really happy to welcome @aklymchenko.bsky.social to open this beautiful day! Thank you very much again for coming ☺️.
042
Reposted by Elise Lepeltier
LabMINT @labmint.bsky.social · 23/05/2025
Congratulations to Dr. Cécile Doualle for your excellent PhD defense! We are all proud of you! Congratulations also to your supervisors Dr. Franck Letournel and Dr. Julien Gouju.
011
Reposted by Elise Lepeltier
Nanoscale Journals @nanoscale-journals.rsc.org · 12/03/2025
Calling all researchers working on nanomedicines for crossing biological barriers 📢 Submit your latest research to this exciting themed collection in Nanoscale by 16 May 2025 🗓 Find out more about the collection and how to submit 🔗 blogs.rsc.org/nr/2024/10/2...
062
Reposted by Elise Lepeltier
LabMINT @labmint.bsky.social · 07/03/2025
A new article from @labmint.bsky.social by notably Dr. Abdallah Ladaycia and Dr. Léna Guyon, supervised by @elepeltier.bsky.social published in @nanoscale-journals.rsc.org: pubs.rsc.org/en/content/a...
pubs.rsc.org
Self-assemblies of cell-penetrating peptides and ferrocifens: design and biological evaluation of an innovative platform for lung cancer treatment
Chemotherapy currently used for lung cancer treatment often consists in a combination of drugs, with a moderate efficacy and severe side effects. A major drawback of the classical inorganic drugs used...
021
Reposted by Elise Lepeltier
LabMINT @labmint.bsky.social · 20/02/2025
New article from @labmint.bsky.social by notably Dr. Claire Gazaille and Dr. Guillaume Bastiat: "Focus on the importance of the process parameters: Temperature cycles and “shock” water addition during the phase inversion process for the formulation of lipid nanoparticles"
011
Reposted by Elise Lepeltier
SFNano_official @sfnano.bsky.social · 07/02/2025
Nous sommes heureux de vous convier à une journée d’échanges autour des « Formulations Lipidiques pour la Libération d’ARN » le jeudi 3 Avril 2025, à la Faculté de Pharmacie Paris 5. Le nombre de places est limité. Inscriptions obligatoires en ligne : framaforms.org/journee-lnp-...
framaforms.org
Journée LNP SFNano | Framaforms.org
021
Elise Lepeltier @elepeltier.bsky.social · 04/12/2024
Congratulations @ZarikianLaura for your great talk at the @SFNano_official annual meeting in @Toulouse : you can be proud of you!
020
Elise Lepeltier @elepeltier.bsky.social · 28/10/2024
Wonderful talk @H_H_Genedy from @LabMint at the @CRSBeNeLuxFr congress to present our PRC @AgenceRecherche NEMESIS project: congratulations ☺️.
010
Elise Lepeltier @elepeltier.bsky.social · 04/07/2024
Excellent talk @H_H_Genedy from @LabMint at #EMJMD_NANOMED Workshop: congratulations !!!
020
Elise Lepeltier @elepeltier.bsky.social · 04/07/2024
Congratulations @MelinaGuerin29 from @LabMint for your excellent presentation at #EMJMD_Nanomed workshop!!!
000
Elise Lepeltier @elepeltier.bsky.social · 03/07/2024
Congratulations Bilel Laoulaou from @RMeS_UMR1229 and from @LabMint for your brilliant talk !! And thank you @AgenceRecherche for the support ! And last but not least: thank you Johann Clouet 😁
000
Elise Lepeltier @elepeltier.bsky.social · 22/02/2024
A beautiful review with @RMeS_UMR1229 in @ADDReditors by notably @H_H_Genedy, Paul Humbert, @Cath_LeVisage, @JeromeGuicheux, @CPassirani and Johann Clouet: first article from our @AgenceRecherche PRC projet “Nemesis”: congratulations to all of you 🥂. sciencedirect.com/science/articl…
000
Elise Lepeltier @elepeltier.bsky.social · 06/12/2023
It was a great @SFNano_official annual meeting in Montpellier, @LabMint was more than well represented: a big thanks to each of you @MelinaGuerin29, @H_H_Genedy, Bilel Laoulaou and Laura Zarikian 😊🎉
000
Elise Lepeltier @elepeltier.bsky.social · 05/12/2023
Congratulations @H_H_Genedy for your great talk at @SFNano_official annual meeting in Montpellier: well done 👍🏻
010
Elise Lepeltier @elepeltier.bsky.social · 14/11/2023
Tellement honorée, merci infiniment @InstUnivFr @LabMint @UA_Recherche @UnivAngers @FacSante_Angers
010
Elise Lepeltier @elepeltier.bsky.social · 17/10/2023
Nous sommes à la recherche d’un étudiant pour un stage de Master 2 au @LabMint dont le sujet porte sur la formulation de nanocapsules lipidiques chargées en ARNm pour le traitement de maladies génétiques de l’œil Si intéressé, envoyez-moi votre CV: elise.lepeltier@univ-angers.fr
000
Elise Lepeltier @elepeltier.bsky.social · 16/08/2023
What a wonderful gift for a chemist 🤩: thank you very much again @Milad_Bar @MelinaGuerin29 @H_H_Genedy @CPassirani @Cooltrail @lautram_no49460 @Lemaire_LabMint @f_franconi, Bilel, Gloria and Laura, I am really lucky 😍!
000
Elise Lepeltier @elepeltier.bsky.social · 11/07/2023
Merci beaucoup @seb_faure 😊 x.com/seb_faure/stat…
000
Elise Lepeltier @elepeltier.bsky.social · 08/06/2023
Your first poster at @icat_sfr seminar @MelinaGuerin29 and not the last one 😊: congratulations 🎉
010
Elise Lepeltier @elepeltier.bsky.social · 25/05/2023
Oooo I still don’t believe in it 😭. Sometimes life can be very difficult, but life can also be really beautiful. Thank you very much @InstUnivFr ! It is such an honor. And of course, thank you all my team of students 😊. @UnivAngers @UA_Recherche @InsermGrdOuest @CNRS x.com/LabMint/status…
010
Elise Lepeltier @elepeltier.bsky.social · 31/03/2023
Today, I was the reviewer of @dasilvalex’s PhD thesis at @umr8612 : congratulations again Alexandre and thank you Sinda Lepêtre and Patrick Couvreur for your invitation 😊.
000
Elise Lepeltier @elepeltier.bsky.social · 24/01/2023
So happy to share with you our last article published in @ACS_Langmuir from @IdlasP’s PhD Thesis founded by @AgenceRecherche with @Feroscan_PSL 🤩!! Thanks all the co-authors, notably @GBastiat, @CPassirani, Prof. Jaouen and Prof. Vessières! pubs.acs.org/doi/10.1021/ac…
pubs.acs.org
Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure
Ferrocifens, lipophilic organometallic complexes, comprise a biologically active redox motif [ferrocenyl-ene-p-phenol] which confers very interesting cytotoxic properties to this family. However, because of their highly lipophilic nature, a formulation stage is required before being administered in vivo. In recent decades, ferrocifen lipid nanocapsules (LNCs) have been successfully formulated and have demonstrated anticancer activity on multidrug-resistant cancers in several mice and rat models (glioblastoma, breast cancer, and metastatic melanoma). A recent family of ferrocifens (succinimidoalkyl-ferrociphenols, including P722) appears to be most efficacious on several resistant cancer cell lines, with IC50 values in the nanomolar range together with promising in vivo results on murine ovarian cancer models. As LNCs are composed of an oily core (caprylic/capric triglycerides), modulation of the succinimido-ferrociphenol lipophilicity could be a valuable approach toward improving the drug loading in LNCs. As the drug loading of the diphenol P722 in LNCs was low, it was structurally modified to increase its lipophilicity and thereby the payload in LNCs. Chemical modification led to a series of five succinimido-ferrocifens. Results confirmed that these slight structural modifications led to increased drug loading in LNCs for all ferrocifens, with no reduction of their cytotoxicity on the SKOV3 ovarian cancer cell line. Interestingly, encapsulation of two of the ferrocifens, diester P769 and monophenolic ester (E)-P998, led to the formation of a gel. This was unprecedented behavior, a phenomenon that could be rationalized in terms of the positioning of ferrocifens in LNCs as shown by the decrease of interfacial tension measurements at the water/oil interface. Moreover, these results highlighted the importance of obtaining a gel of this particular motif, in which the acetylated phenolic ring and the succinimidoalkyl moieties are mutually cis relative to the central double bond. Promising perspectives to use these ferrocifen-loaded LNCs to treat glioblastoma could be readily envisaged by local application of the gel in the cavity after tumor resection.
000
Elise Lepeltier @elepeltier.bsky.social · 21/12/2022
Please RT would be appreciated, thank you 😊 x.com/LabMint/status…
000
Elise Lepeltier @elepeltier.bsky.social · 02/12/2022
Tellement fière de toi @IdlasP !! 🦾 x.com/LabMint/status…
000
Elise Lepeltier @elepeltier.bsky.social · 30/09/2022
Thank you @icat_sfr ☺️ x.com/icat_sfr/statu…
000
Elise Lepeltier @elepeltier.bsky.social · 09/09/2022
Congratulations @IdlasP and @A_Ladaycia for this work 😊🎉 x.com/LabMint/status…
000
Elise Lepeltier @elepeltier.bsky.social · 05/07/2022
A new article between @LabMint and @RMeS_UMR1229, from the PhD work of @BrianLemoal with notably as authors @JeromeGuicheux, @Cath_LeVisage, @CPassirani: congratulations 😊 authors.elsevier.com/a/1fMQo1M49kXF…
000
Elise Lepeltier @elepeltier.bsky.social · 01/07/2022
Nemesis project accepted by @AgenceRecherche led by @RMeS_UMR1229 🍾🍾🍾: a huge recognition of our collaboration 🤩 @LabMint
000
Elise Lepeltier @elepeltier.bsky.social · 30/06/2022
Proud of you 😊 @Milad_Bar x.com/LabMint/status…
000
Elise Lepeltier @elepeltier.bsky.social · 12/04/2022
Congratulations @BrianLemoal, well done 👍🏻, thesis co-supervised with Prof Johann Clouet, between @RMeS led by @JeromeGuicheux and @LabMint leb by Patrick Saulnier.
000
Elise Lepeltier @elepeltier.bsky.social · 11/02/2022
Congratulations my dear Docteur @A_Ladaycia for your PhD Thesis: you were excellent 🤩!!! It was a pleasure to share this project with you ☺️. @LabMint @Feroscan_PSL
000
Elise Lepeltier @elepeltier.bsky.social · 06/12/2021
When you are more than happy to see in reality the congress you started to organize two year ago @SFNano_official 🥰
000
Elise Lepeltier @elepeltier.bsky.social · 01/12/2021
When you are doing the participants’ bags for the next @SFNano_official annual meeting on Monday 🤩
000
Elise Lepeltier @elepeltier.bsky.social · 27/11/2021
When you organize a congress and you watch the news on 📺 about the new sanitary measures: @SFNano_official the congress is in 9 days, we will do it 🦾. @chantal_pichon @NTsapis @nathalie_mignet @LucieSancey @ElisGaranger @begu_sylvie
000
Elise Lepeltier @elepeltier.bsky.social · 02/11/2021
A new article from @LabMint by @A_Ladaycia and @CPassirani in @ELSpharma EJPB : your second paper @A_Ladaycia, congratulations! Microbiota and Nanoparticles: Description and Interactions sciencedirect.com/science/articl…
000
Elise Lepeltier @elepeltier.bsky.social · 09/07/2021
Congratulations @A_Ladaycia : it was great 😊🦾 x.com/bricecalvignac…
000
Elise Lepeltier @elepeltier.bsky.social · 20/04/2021
When you feel happy to have in your left arm the object of your research: First dose of Pfizer vaccination 💉✅.
000
Elise Lepeltier @elepeltier.bsky.social · 13/03/2021
13/03/20: cela parrait si loin et pourtant si près. Mon HDR. Avec vous, ma famille et amis. Dernier restaurant à plus de 60, dernière boîte de nuit. Et une Elise malheureusement si différente de celle d’aujourd’hui... Mais non, je ne ferai pas le deuil de cette femme, jamais...
000
Elise Lepeltier @elepeltier.bsky.social · 20/12/2020
J’ai découvert la start-up Juliette qui a été créée pour changer le monde avec des produits bons pour soi et pour la planète. J’ai envie de les soutenir, tu veux m’aider ? Ils organisent un super concours pour les aider à se lancer ici : juliette.com/?referrer=f0a9…
000
Elise Lepeltier @elepeltier.bsky.social · 27/08/2020
New article from @GasserGroup and notably @LabMint 😊: Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as Novel Drug Candidates for Schistosomiasis …mistry-europe.onlinelibrary.wiley.com/doi/10.1002/ch…
chemistry-europe.onlinelibrary.wiley.com
Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as New Drug Candidates for Schistosomiasis**
Testing alternatives: Schistosomiasis is a disease of poverty affecting millions of people. In this investigation, in-depth preclinical studies on three lead compounds derived from oxamniquine were c...
000
Elise Lepeltier @elepeltier.bsky.social · 27/07/2020
Off for 3 weeks
000
Elise Lepeltier @elepeltier.bsky.social · 01/04/2020
Merci beaucoup pour ce retour: notre centaine d’étudiants de @FacSante_Angers sont investis à 200% pour produire plus de 5000 masques par jour, pour vous. Merci pour eux 😊😷@chu_angers @UnivAngers @NLerolle x.com/LauraBlkA/stat…
000
Elise Lepeltier @elepeltier.bsky.social · 23/03/2020
Mince, je suis démasquée... 😂 x.com/julnicolas/sta…
000
Elise Lepeltier @elepeltier.bsky.social · 23/03/2020
When @GBastiat @Lemaire_LabMint and @CPassirani organize a meeting: it looks like that now 😅😷. @LabMint @FacSante_Angers
000
Elise Lepeltier @elepeltier.bsky.social · 07/02/2020
Supramolecular Nanomaterials for Engineering, Drug Delivery, and Medical Applications frontiersin.org/research-topic…
frontiersin.org
Frontiers | Supramolecular Nanomaterials for Engineering, Drug Delivery, and Medical Applications
Programmed self-assembly and self-organization of carefully designed molecular monomers has been widely explored to engineer stable nanostructures with the d...
000
Elise Lepeltier @elepeltier.bsky.social · 12/12/2019
So happy to enter in the #SFnano board: I gave my first oral communication at a GTRV congress, when I was a baby researcher: illustration of how #SFnano is important for me ☺️
000
Elise Lepeltier @elepeltier.bsky.social · 05/11/2019
Proud of you @LenaGuyon_univ : thank you very much @NTsapis @nathalie_mignet Nicolas Delsuc, François Ganachaud and of course @CPassirani 😊
000
Elise Lepeltier @elepeltier.bsky.social · 15/10/2019
Toutes mes félicitations @Biomac_ACS_Bord 🎉 x.com/julnicolas/sta…
000